Evidence map›Paper›PMID 40153356›Full record

ArticleAmerican journal of epidemiology2026

Interactions between genetic and epidemiological factors influencing mammographic density.

Austin Hammermeister Suger, Hongjie Chen, Cameron B Haas, Shaoqi Fan, Christopher G Scott, Manjeet K Bolla, Joe Dennis, Alison M Dunning, Kyriaki Michailidou, Qin Wang and 29 more

Abstract read
In one paragraph

Article in American journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors.

Austin Hammermeister SugerDepartment of Epidemiology, University of Washington School of Public Health, 3980 15th Ave NE, Seattle, WA 98195, United States.ORCID 0000-0002-6599-2202
Hongjie ChenDepartment of Epidemiology, University of Washington School of Public Health, 3980 15th Ave NE, Seattle, WA 98195, United States.ORCID 0000-0002-6438-108X
Cameron B HaasDepartment of Epidemiology, University of Washington School of Public Health, 3980 15th Ave NE, Seattle, WA 98195, United States.
Shaoqi FanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Dr, Bethesda, MA 20892, United States.ORCID 0000-0001-5894-7510
Christopher G ScottDepartment of Quantitative Health Sciences, Division of Clinical Trials and Biostatistics, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, United States.
Manjeet K BollaDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, United Kingdom.ORCID 0000-0002-4351-9326
Joe DennisDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, United Kingdom.ORCID 0000-0003-4591-1214
Alison M DunningDepartment of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, United Kingdom.
Kyriaki MichailidouDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, United Kingdom.ORCID 0000-0001-7065-1237
Qin WangDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, United Kingdom.ORCID 0000-0002-9139-0627
Peter A FaschingDepartment of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Maximiliansplatz 2, Erlangen 91054, Germany.
Lothar HaeberleDepartment of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, University Hospital Erlangen, Maximiliansplatz 2, Erlangen 91054, Germany.
Jennifer StoneGenetic Epidemiology Group, School of Population and Global Health, University of Western Australia, 35 Stirling Hwy, Perth, WA 6009, Australia.ORCID 0000-0001-5077-0124
Manuela Gago-DominguezCancer Genetics and Epidemiology Group, Genomic Medicine Group, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Travesía da Choupana S/N, Santiago de Compostela 15706, A Coruña, Spain.
Jose E CastelaoOncology and Genetics Unit, Instituto de Investigación Sanitaria Galicia Sur, SERGAS, Estrada Clara Campoamor n° 341, Vigo 36312, Pontevedra, Spain.
Rachel A MurphySchool of Population and Public Health, University of British Columbia, 2206 East Mall, Vancouver, BC V6T 1Z3, Canada.
Kristan AronsonPublic Health Sciences, Queen's University, Level 2, 10 Stuart Street, Kingston, ON K7L 3N6, Canada.
Fergus J CouchDepartment of Laboratory Medicine and Pathology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, United States.
Siddhartha YadavDepartment of Medical Oncology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, United States.ORCID 0000-0003-4630-9903
Roger L MilneCancer Epidemiology Division, Cancer Council Victoria, 200 Victoria Parade, Melbourne, VIC 3002, Australia.ORCID 0000-0001-5764-7268
John L HopperCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, 207 Bouverie Street, Melbourne, VIC 3010, Australia.
Aaron NormanDepartment of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, United States.
A Heather EliassenChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, 3rd Floor, Boston, MA 2115, United States.
William J TapperFaculty of Medicine, University of Southampton, 12 University Road, Southampton SO17 1BJ, United Kingdom.
Diana M EcclesFaculty of Medicine, University of Southampton, 12 University Road, Southampton SO17 1BJ, United Kingdom.
D Gareth EvansDivision of Evolution, Infection and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Oxford Road, Manchester M13 9WL, United Kingdom.
Susan AstleyDivision of Informatics, Imaging and Data Science, University of Manchester, Oxford Road, Manchester M13 9WL, United Kingdom.
Per HallDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, P.O. Box 281/Nobelsväg 12 A, Stockholm 171 65, Sweden.ORCID 0000-0002-5640-9126
Kamila CzeneDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, P.O. Box 281/Nobelsväg 12 A, Stockholm 171 65, Sweden.ORCID 0000-0002-3233-5695
Paul D P PharoahDepartment of Computational Biomedicine, Cedars-Sinai Medical Center, West Hollywood, CA 90069, United States.ORCID 0000-0001-8494-732X
Antonis C AntoniouDepartment of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, United Kingdom.
Montserrat García-ClosasDivision of Genetics and Epidemiology, The Institute of Cancer Research (ICR), 123 Old Brompton Road, London SW7 3RP, United Kingdom.ORCID 0000-0003-1033-2650
Amy BerringtonDivision of Genetics and Epidemiology, The Institute of Cancer Research (ICR), 123 Old Brompton Road, London SW7 3RP, United Kingdom.
Douglas F EastonDepartment of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, 2 Worts' Causeway, Cambridge CB1 8RN, United Kingdom.ORCID 0000-0003-2444-3247
Gretchen L GierachDivision of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Dr, Bethesda, MA 20892, United States.
Rulla M TamimiDepartment of Population Health Sciences, Weill Cornell Medicine, New York, NY 10065, United States.
Celine M VachonDepartment of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, United States.
Sara LindströmDepartment of Epidemiology, University of Washington School of Public Health, 3980 15th Ave NE, Seattle, WA 98195, United States.
Tabitha A HarrisonDepartment of Epidemiology, University of Washington School of Public Health, 3980 15th Ave NE, Seattle, WA 98195, United States.

Funding

Statistical MethodsP01CA087969 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, TAMIMI, RULLA M · 2000 to 2019
$77.8M
The Role of CHFR in Tumorigenesis and Paclitaxel-Sensitivity in Breast CancerP50CA116201 · NCI · MAYO CLINIC ROCHESTER · PI PETER C LUCAS · 2005 to 2026
$49.9M
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3M
Life Course Cancer Epidemiology Cohort in WomenUM1CA176726 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2013 to 2017
$15.7M
Epidemiologic StudiesU19CA148065 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI AHSAN, HABIBUL, BRUGGE, JOAN SIEFERT · 2010 to 2014
$10.6M
Epidemiological and Clinical Translational Studies Post Genome-Wide AssociationU19CA148537 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EASTON, DOUGLAS FREDERICK, EELES, ROSALIND · 2010 to 2014
$10.4M
Ovarian cancer GWAS discovery, expansion and replication (N2 - Project #1)U19CA148112 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI SELLERS, THOMAS A · 2010 to 2014
$10.2M
Developing Data-Driven Cancer ResearchersT32CA009168 · NCI · UNIVERSITY OF WASHINGTON · PI STEPHEN M SCHWARTZ, MICHAEL Chiao-An WU · 1985 to 2026
$10.1M
Resolving the cancer relevance of predisposition gene mutationsR35CA253187 · NCI · MAYO CLINIC ROCHESTER · PI Fergus Joseph Couch · 2020 to 2026
$5.8M
A genome-wide association study for breast cancer in BRCA1 mutation carriersR01CA128978 · NCI · MAYO CLINIC ROCHESTER · PI COUCH, FERGUS JOSEPH · 2008 to 2012
$4.8M
A Mayo Cohort Study of Mammographic Breast DensityR01CA097396 · NCI · MAYO CLINIC ROCHESTER · PI VACHON, CELINE M · 2003 to 2007
$3.1M
Automated Density Measures for Estimating Breast Cancer Risk and Therapy ResponseR01CA177150 · NCI · MAYO CLINIC ROCHESTER · PI KERLIKOWSKE, KARLA M, VACHON, CELINE M · 2013 to 2017
$3.0M
Acción Estratégica de Salud del Instituto de Salud Carlos III PI12/02125Acción Estratégica de Salud del Instituto de Salud Carlos III PI13/01136Acción Estratégica de Salud del Instituto de Salud Carlos III PI17/00918Agency for Science, Technology and Research of Singapore (A*STAR), the US National Institute of Health (NIH) and the Susan G. Komen Breast Cancer FoundationAustralian National Health and Medical Research Council 1074383Australian National Health and Medical Research Council 396414Canadian Cancer Society 313404Cancer Research UK 2010PR62Cancer Research UK 2013PR044Cancer Research UK C12292/A11174Cancer Research UK C1275/A11699Cancer Research UK C1275/A15956Cancer Research UK C1275/A19187Cancer Research UK C1275/C22524Cancer Research UK C1281/A12014Cancer Research UK C1287/A10118Cancer Research UK C1287/A10710Cancer Research UK C1287/A16563Cancer Research UK C490/A10124Cancer Research UK C490/A16561Cancer Research UK C5047/A10692Cancer Research UK C5047/A15007Cancer Research UK C5047/A8384Cancer Research UK C8197/A16565Cancer Research UK PPRPGM-Nov20\100002Consellería de Industria Programa Sectorial de Investigación Aplicada, PEME I + D e I + D Suma del Plan Gallego de Investigación, Desarrollo e Innovación Tecnológica de la Consellería de Industria de la Xunta de Galicia, Spain EC11-192Department of DefenceEuropean Community's Seventh Framework ProgramGenome Canada and the Canadian Institutes of Health Research GPH-129344Genome Canada and the Canadian Institutes of Health Research, the Ministère de l'Économie et de l'Innovation du Québec through Genome Québec, the Quebec Breast Cancer FoundationMinistère de l'Économie, Science et Innovation du Québec through Genome Québec PSRSIIRI-701National Cancer Institute Intramural Research Program, National Institutes of Health, the European Union's Horizon 2020 Research and Innovation ProgramNational Cancer Institute (NCI), National Institutes of Health (NIH) CA244670NCI NIH HHS P01 CA087969NCI NIH HHS P50 CA116201NCI NIH HHS R01 CA097396NCI NIH HHS R01 CA128931NCI NIH HHS R01 CA128978NCI NIH HHS R01 CA140286NCI NIH HHS R01 CA177150NCI NIH HHS R01 CA244670NCI NIH HHS R35 CA253187NCI NIH HHS T32 CA009168NCI NIH HHS U19 CA148065NCI NIH HHS U19 CA148112NCI NIH HHS U19 CA148537NCI NIH HHS UM1 CA176726NCI NIH HHS UM1 CA186107NIH HHS CA116201NIH HHS CA128931NIH HHS CA128978NIH HHS CA140286NIH HHS CA177150NIH HHS CA97396NIH HHS P01 CA87969NIH HHS P50CA116201NIH HHS R35CA253187NIH HHS U19 CA148065NIH HHS UM1 CA176726NIH HHS UM1 CA186107NIHR PGfAR 0707-10031NIHR Cambridge Biomedical Research Centre NIHR203312Post-Cancer GWAS 1 U19 CA148065Post-Cancer GWAS 1 U19 CA148112Post-Cancer GWAS 1 U19 CA148537Programa Grupos Emergentes, Cancer Genetics Unit, Instituto de Investigacion Biomedica Galicia Sur. Xerencia de Xestion Integrada de Vigo-SERGAS, Instituto de Salud Carlos III, Spain 10CSA012EWellcome Trust 209057
6 · The paper itself

Abstract

Studies have identified genetic and epidemiologic factors associated with mammographic density (MD) phenotypes. However, MD-associated genetic variants only account for a small proportion of the total estimated heritability. Interrogating interactions between genetic and epidemiologic factors could potentially identify additional MD-associated loci, expand our understanding of the genetic basis of MD phenotypes, and clarify how epidemiologic factors modulate relationships between genetic variants and MD. We conducted six separate genome-wide, gene-environment (GxE) interaction analyses, applying 2 degrees of freedom (df) and 1df interaction tests, for each of three MD phenotypes (percent density, dense area (DA), and nondense area (NDA)). The six epidemiologic factors considered were height, ever parous, parity, ever menopausal hormone therapy, ever breastfeeding, and months of breastfeeding. We included European ancestry participants from multiple studies within the Markers of Density consortium and the Breast Cancer Association Consortium (n = 4895-16 218 depending on specific analyses). We identified 11 loci with genome-wide significant (P < 5 × 10-8) interaction tests including two novel common genetic signals interacting with parity (8p21.2) and ever breastfeeding (19p13.2) for NDA. Our results suggest that epidemiologic risk factors might influence relationships between common genetic variants and MD phenotypes at particular genomic loci.

Indexed as

Breast DensityBreast NeoplasmsGene-Environment InteractionAdultBreast FeedingFemaleGenome-Wide Association StudyHumansMammographyMiddle AgedParityPhenotypePolymorphism, Single NucleotideRisk Factorsgene–environment interactionsgenetic association studyGWASmammographic density

Identifiers

PMID40153356
PMCPMC13016711

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.